日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations

一项泛欧洲肺癌患者病例回顾研究比较了铂类化疗后使用阿米万单抗与真实世界医生选择的药物治疗方案,这些患者均携带EGFR 20号外显子插入突变并处于激活状态

Christopoulos, Petros; Girard, Nicolas; Proto, Claudia; Soares, Marta; Lopez, Pilar Garrido; van der Wekken, Anthonie J; Popat, Sanjay; Diels, Joris; Schioppa, Claudio A; Sermon, Jan; Rahhali, Nora; Pick-Lauer, Corinna; Adamczyk, Agnieszka; Penton, James; Wislez, Marie

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

RESONATE-2™ 和 RESONATE™ 研究中单药伊布替尼与真实世界 PHEDRA 数据库中治疗慢性淋巴细胞白血病患者的疗效比较

Salles, Gilles; Bachy, Emmanuel; Smolej, Lukas; Simkovic, Martin; Baseggio, Lucile; Panovska, Anna; Besson, Hervé; Healy, Nollaig; Garside, Jamie; Iraqi, Wafae; Diels, Joris; Pick-Lauer, Corinna; Spacek, Martin; Urbanova, Renata; Lysak, Daniel; Hermans, Ruben; Lundbom, Jessica; Callet-Bauchu, Evelyne; Doubek, Michael